Linda Stocum, Associate Editor

In this drug pipeline interview, Christopher Bunick, MD, PhD, discusses what is innovative in future acne treatment options, what research is happening, and what potential approvals the dermatology space has to look forward to.

Mindera Health and a national health insurance company launched a pilot program to improve moderate-to-severe psoriasis management with precision medicine.

Dermavant’s new topical treatment for plaque psoriasis in adults was approved by the FDA this morning.

Recent data tracks the first realization of precision medicine for patients with psoriasis.

This week's edition of the Mainstream Patients features stories about the top 10 best acne-fighting ingredients and medications in 2022, Bill Nye talks not using oil on the scalp, and more.

A Portuguese study examined the association between the use of anti-aging products and the self-esteem of the women who used them.

ICYMI, this week we had stories from the 2022 American College of Mohs Surgery Annual Meeting, bimekizumab's FDA set back, and more.

The Skin Cancer Foundation at its Annual Champions for Change Gala in New York, New York, raised the money while also honoring 157 dermatologists for volunteering with the Foundations skin cancer screening program on May 12.

In this episode, the topics up for discussion include possible technologies to help atopic dermatitis patient adherence with treatment along with new strategies to improve patient experiences at the practice.

UCB announced the FDA issued a CRL that stated that the FDA cannot approve the BLA in its current form.

ICYMI, this week we had stories from the 2022 American College of Mohs Surgery Annual Meeting, a potential melanoma surge, and more.

A poster at the 2022 American College of Mohs Surgery Annual Meeting examined the prevalence of bacterial organism colonization in Mohs wounds left to secondary intention.

Surgical site infections (SSIs) are a common adverse event after Mohs Micrographic Surgery, but researchers aimed to find out how the clinical features of gram-negative differ from their counterparts.

Starting today, the American College of Mohs Surgery is having their 54th Annual Meeting in Philadelphia, Pennsylvania.

Teenagers were the most likely to be affected by targeted misinformation.

VialConnect is a clinical trials management system built for coordinators and investigators

Nonmelanoma skin cancer ranks in the top 12 skin diseases reported.

This week's edition of the Mainstream Patients features stories about treating scars, jojoba oil for skin, and more.

Ruxolitinib cream 1.5% may soon be the first FDA-approved treatment for repigmentation of vitiligo. Experts share what dermatologists need to know regarding efficacy, safety, and cost of this topical drug.

Allergic contact dermatitis and atopic dermatitis are common causes of rashes in the pediatric population. Patch testing can help demystify the cause of such skin conditions and determine treatment.

Julie Harper, MD, talks about the Epsolay drug approval that happened April 25. She dives into its mechanism of action, its potential as both a first line treatment or combination therapy, and what she would like to see next in its research.

Savina Aneja, MD, highlights the importance of Melanoma Monday and gives clinical pearls on how to counsel patients, skin cancer screenings, and more.

Zoe Diana Draelos, MD, gives the details on sun protective clothing, including how it doesn't need to break the bank, how to test how protective clothing is, and a hat might be the most important piece of sun protection.

ICYMI, this week we had stories on Epsolay's FDA approval for rosacea, conference coverage, and more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of April.

The 2022 New Wave Dermatology Conference started with several workshops and promises to bring a multitude of clinical pearls to the table.

The designation is for the treatment of X-linked recessive ichthyosis (XRI) and autosomal recessive congenital ichthyosis lamellar ichthyosis (ARCI-LI).

The American Academy of Dermatology’s survey finds more Americans say sun protection is more important than 5 years ago, but don’t understand how to protect themselves.

Sol-Gel Technologies and Galderma announce the FDA approval of the 5% benzoyl peroxide, cream for the treatment of inflammatory lesions of rosacea.

The Skin Cancer Foundation's mobile education program is set to cross the United States to both raise skin cancer awareness and provide free skin cancer screenings.